Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0025-7753(02)73319-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bruising, hives, and joint pain in a 3-year-old boy.
JAAD Case Rep
January 2025
Department of Dermatology, Medical College of Georgia at Augusta University, Augusta, Georgia.
Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease.
Children (Basel)
November 2024
Division of Gastroenterology, Department of Pediatrics, University of New Mexico, Albuquerque, NM 87131, USA.
Infliximab (IFX) is a recombinant DNA-derived chimeric IgG monoclonal antibody protein that inhibits tumor necrosis factor alpha (TNF-α). IFX, like other agents derived from foreign proteins, can cause infusion reactions both during and after the infusion. The incidence of infusion reactions ranges between 0% and 15% in pediatric patients.
View Article and Find Full Text PDFClinical presentation and management of children with suspected serum sickness-like reaction.
J Allergy Clin Immunol Pract
December 2024
Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Mo; University of Missouri-Kansas City School of Medicine, Kansas City, Mo. Electronic address:
Serum Sickness and Serum Sickness-Like Reactions Presenting to Pediatric Hospital.
Clin Pediatr (Phila)
August 2024
Division of Pediatric Emergency Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Correction: Serum sickness-like reaction to D-Supplement: A Case Report.
BMC Pediatr
July 2024
Department of Gynecology and Urogynecology, Milford Regional Medical Center, 14 Prospect Street, Milford, MA, 01757, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!